# Timothy F. Cloughesy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/timothy-f-cloughesy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 64,423 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 128 |
| i10-index | 468 |
| Last Known Institution | University of California, Los Angeles |
| OpenAlex ID | https://openalex.org/A5063511816 |
| ORCID iD | https://orcid.org/0000-0002-8656-7483 |
| Works | 1,350 |

## Researcher papers

- [Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma](https://scholariq.org/papers/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with/)
- [Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma](https://scholariq.org/papers/vorasidenib-in-idh1-or-idh2-mutant-low-grade-glioma/)
- [Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme](https://scholariq.org/papers/phase-ii-study-of-bevacizumab-plus-temozolomide-during-and-after-radiation/)
- [Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin](https://scholariq.org/papers/evidence-for-sequenced-molecular-evolution-of-i-idh1-i-mutant-glioblastoma-from/)
- [Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.](https://scholariq.org/papers/imaging-proliferation-in-brain-tumors-with-18f-flt-pet-comparison-with-18f-fdg/)
- [Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies](https://scholariq.org/papers/somatic-mutations-of-the-parkinson-s-disease-associated-gene-park2-in/)
- [Federated learning enables big data for rare cancer boundary detection](https://scholariq.org/papers/federated-learning-enables-big-data-for-rare-cancer-boundary-detection/)
- [Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors](https://scholariq.org/papers/differential-sensitivity-of-glioma-versus-lung-cancer-specific-egfr-mutations-to/)
- [Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment](https://scholariq.org/papers/recurrent-glioblastoma-multiforme-adc-histogram-analysis-predicts-response-to/)
- [MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy](https://scholariq.org/papers/mri-in-patients-with-high-grade-gliomas-treated-with-bevacizumab-and/)
- [Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial](https://scholariq.org/papers/vorasidenib-a-dual-inhibitor-of-mutant-idh1-2-in-recurrent-or-progressive-glioma/)
- [Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial](https://scholariq.org/papers/vorasidenib-and-ivosidenib-in-idh1-mutant-low-grade-glioma-a-randomized/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [MRI in cancer diagnosis](https://scholariq.org/topics/mri-in-cancer-diagnosis/)

## Researcher university

- [University of California, Los Angeles](https://scholariq.org/institutions/university-of-california-los-angeles/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.